Cordlife Group is a consumer healthcare company focused on the well-being of mothers and children, with a significant presence in the Asia Pacific region. The company has over 19 years of expertise in stem cell processing and cryopreservation, making it the largest network of private stem cell banks in the region. Cordlife operates in two main segments: the Banking segment, which includes services for cord blood, cord lining, and cord tissue, and the Diagnostics segment, offering non-invasive screening services such as Metascreen for newborns, non-invasive prenatal testing, and Eyescreen for pediatric eye health. With state-of-the-art facilities in Singapore, Hong Kong, Malaysia, India, Indonesia, and the Philippines, Cordlife also has a strategic brand presence in several other countries, including Thailand, Vietnam, Myanmar, and Bangladesh.
HealthBaby Biotech operates as a private cord blood bank, where it has been operating since 2006 and has stored approximately 20,000 cord blood units to date.
Stemlife Berhad
Acquisition in 2015
StemLife Berhad is an investment holding company based in Kuala Lumpur, Malaysia, specializing in stem cell banking services for newborns. The company is involved in the collection, testing, processing, and preservation of umbilical cord blood stem cells, umbilical cord tissue, Wharton Jelly, and peripheral blood stem cells. Additionally, StemLife offers stem cell therapy and consultancy services. The company's stem cell products are utilized in bone marrow transplantation for pediatric leukemia and in the treatment of various conditions, including blood-related disorders, heart disease, foot ulcers, and sports injuries. Established in 2001, StemLife Berhad is a subsidiary of Cordlife Group Limited.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.